Agilik@Home: Demonstrate the Clinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if a two month training with the Agilik powered orthosis improves the knee extension or the endurance in pediatric patients with Cerebral palsy and a crouch gait. It will also learn about the safety of Agilik. The main questions it aims to answer are: Does the Agilik powered orthosis increase the value of the knee extension during walking? What medical problems do participants have when using the Agilik powered orthosis? Researchers will compare a group of patients using the Agilik powered exoskeleton with a group of patients treated with standard therapy. Participants will: Use Agilik at home or perform standard therapy for 2 months Visit the clinic at the beginning of the study, after 3 months and after 1 additional month.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 17
Healthy Volunteers: f
View:

• Diagnosis of CP and a crouch gait

• Provision of signed and dated informed consent form.

• Stated willingness to comply with all study procedures and availability for the duration of the study, or alternatively, ability to do so based on parent report and physician observation during history and physical examination.

• Body weight between 20 and 125 Kg

• Knee flexion retraction assessed in supine position by less than 10°. Hamstring contracture as assessed by straight leg raising test does not limit ability to participate in the study.

• Subjects must not have had a tibio-tarsal arthrodesis. In addition, they must have at least 5° of passive dorsi-flexion of the ankle.

• Able to walk at least 3 m without stopping, with or without a walking aid.

• Able to understand and follow simple directions based on parent report and physician observation during historical and physical examination.

• GMFCS level I, II and III

• MAS score ≤ 2

Locations
Other Locations
Italy
IRCCS E. MEDEA - Associazione La Nostra Famiglia
RECRUITING
Bosisio Parini
IRCCS Fondazione Stella Maris
NOT_YET_RECRUITING
Calambrone
Fondazione Don Carlo Gnocchi Onlus - IRCCS S. Maria Nascente
RECRUITING
Milan
Fondazione Mondino
NOT_YET_RECRUITING
Pavia
Fondazione Don Carlo Gnocchi Onlus
RECRUITING
Roma
Fondazione Don Carlo Gnocchi Onlus - Centro S. Maria al Mare
RECRUITING
Salerno
Contact Information
Primary
Emilia Biffi, PhD
emilia.biffi@lanostrafamiglia.it
+39031877862
Backup
Cristina Maghini, MD
cristina.maghini@lanostrafamiglia.it
Time Frame
Start Date: 2024-10-29
Estimated Completion Date: 2026-07
Participants
Target number of participants: 40
Treatments
Experimental: Intervention Arm
Home rehabilitation
No_intervention: Control Group
Related Therapeutic Areas
Sponsors
Collaborators: Fondazione Don Carlo Gnocchi Onlus, IRCCS Fondazione Stella Maris, Fondazione Mondino
Leads: IRCCS Eugenio Medea

This content was sourced from clinicaltrials.gov